Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

ClinicalTrials.gov ID: NCT01016015

Public ClinicalTrials.gov record NCT01016015. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study of Temsirolimus (CCI-779, NSC 683864) and IGF-1 Receptor Antibody Cixutumumab (IMC-A12, NSC 742460) in Patients With Metastatic Sarcomas

Study identification

NCT ID
NCT01016015
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
178 participants

Conditions and interventions

Interventions

  • Cixutumumab Biological
  • Laboratory Biomarker Analysis Other
  • Temsirolimus Drug

Biological · Other · Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2009
Primary completion
Jun 30, 2014
Completion
Jun 30, 2014
Last update posted
Jul 29, 2015

2009 – 2014

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095
Mayo Clinic in Florida Jacksonville Florida 32224-9980
Moffitt Cancer Center Tampa Florida 33612
Northwestern University Chicago Illinois 60611
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637
Decatur Memorial Hospital Decatur Illinois 62526
NorthShore University HealthSystem-Evanston Hospital Evanston Illinois 60201
Memorial Medical Center Springfield Illinois 62781-0001
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201
University of Michigan University Hospital Ann Arbor Michigan 48109
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Minnesota 55905
Memorial Sloan-Kettering Cancer Center New York New York 10065
SUNY College at Old Westbury Old Westbury New York 11568-0210
Albert Einstein College of Medicine The Bronx New York 10461
Montefiore Medical Center - Moses Campus The Bronx New York 10467-2490
Carolinas Medical Center Charlotte North Carolina 28203
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232
M D Anderson Cancer Center Houston Texas 77030
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01016015, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2015 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01016015 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →